Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET L DITTUS

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology

NPI
1104817667
CMS profile
321812
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$239.38

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $227.72 15
Education $11.66 1

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
AbbVie, Inc. $88.56 6
Lupin Inc. $39.30 2
Vertical Pharmaceuticals, LLC $33.41 2
Duchesnay USA Incorporated $27.32 2
PFIZER INC. $25.73 2
Radius Health, Inc. $13.40 1
AMAG Pharmaceuticals, Inc. $11.66 1

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET L DITTUS

NPI 1104817667 · CMS profile ID 321812

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology / Gynecology

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104817667?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET L DITTUS, NPI 1104817667, CMS profile ID 321812. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104817667?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JANET L DITTUS, NPI 1104817667, CMS profile ID 321812. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104817667?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JANET L DITTUS, NPI 1104817667, CMS profile ID 321812, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1104817667?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $239.38 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $13.3609/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672869768 CMS
AbbVie, Inc. $12.4609/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992141 CMS
Vertical Pharmaceuticals, LLC $14.1208/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675498509 CMS
AbbVie, Inc. $12.3307/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992131 CMS
Duchesnay USA Incorporated $14.2107/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699526441 CMS
AbbVie, Inc. $14.7206/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992119 CMS
Radius Health, Inc. $13.4005/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683930957 CMS
AbbVie, Inc. $16.7204/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992111 CMS
Vertical Pharmaceuticals, LLC $19.2904/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675498507 CMS
Lupin Inc. $24.7303/21/2019 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 704116961 CMS
PFIZER INC. $12.3703/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672185651 CMS
AbbVie, Inc. $20.5302/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992077 CMS
AMAG Pharmaceuticals, Inc. $11.6602/01/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698513433 CMS
Lupin Inc. $14.5701/25/2019 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 704116959 CMS
Duchesnay USA Incorporated $13.1101/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699526439 CMS
AbbVie, Inc. $11.8001/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647992091 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $239.38 16
PY2020 $58.91 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $76,960.26 59
PY2024 Principal investigator $125,208.78 84
PY2023 Principal investigator $164,586.56 110
PY2022 Principal investigator $206,862.26 97
PY2021 Principal investigator $276,121.42 137
PY2020 Principal investigator $399,361.17 89
PY2019 Principal investigator $337,852.09 56

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

59 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $39.49 12/31/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202535241
Principal investigator 1 ABBVIE INC. $90.00 12/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202529704
Principal investigator 1 ABBVIE INC. $79.00 12/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202529716
Principal investigator 1 ABBVIE INC. $2,061.25 12/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202529718
Principal investigator 1 ABBVIE INC. $1,243.75 12/04/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202527380
Principal investigator 1 ABBVIE INC. $90.00 12/04/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202527628
Principal investigator 1 ABBVIE INC. $53.12 11/26/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202525608
Principal investigator 1 ABBVIE INC. $102.00 11/20/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202524892
Principal investigator 1 ABBVIE INC. $102.00 11/13/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202524191
Principal investigator 1 ABBVIE INC. $3,008.13 11/13/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202524193
Principal investigator 1 ABBVIE INC. $556.25 11/13/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202524195
Principal investigator 1 ABBVIE INC. $306.00 11/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202523655
Principal investigator 1 ABBVIE INC. $9,395.63 11/04/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202520657
Principal investigator 1 ABBVIE INC. $45.64 10/28/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202518719
Principal investigator 1 ABBVIE INC. $26.56 10/14/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202516629
Principal investigator 1 ABBVIE INC. $1,960.00 10/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202513923
Principal investigator 1 ABBVIE INC. $37.70 09/30/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202512782
Principal investigator 1 ABBVIE INC. $52.68 09/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202510298
Principal investigator 1 ABBVIE INC. $7,309.38 09/03/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202507123
Principal investigator 1 ABBVIE INC. $1,100.00 08/21/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202505523
Principal investigator 1 ABBVIE INC. $763.75 08/21/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202505525
Principal investigator 1 ABBVIE INC. $19.68 08/19/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202505137
Principal investigator 1 ABBVIE INC. $74.09 08/07/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202504029
Principal investigator 1 ABBVIE INC. $49.39 08/07/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202504031
Principal investigator 1 ABBVIE INC. $90.00 08/05/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202502048
Principal investigator 1 ABBVIE INC. $7,059.38 08/05/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202502140
Principal investigator 1 ABBVIE INC. $90.00 07/15/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202498232
Principal investigator 1 ABBVIE INC. $59.25 07/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202497878
Principal investigator 1 ABBVIE INC. $49.38 07/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202497880
Principal investigator 1 ABBVIE INC. $527.50 07/02/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202494873
Principal investigator 1 ABBVIE INC. $3,575.63 06/18/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202492153
Principal investigator 1 ABBVIE INC. $226.98 06/12/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202491155
Principal investigator 1 ABBVIE INC. $74.59 05/22/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202485845
Principal investigator 1 ABBVIE INC. $3,085.00 05/06/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202481715
Principal investigator 1 ABBVIE INC. $74.11 04/24/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202479079
Principal investigator 1 ABBVIE INC. $10.99 04/24/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202479083
Principal investigator 1 ABBVIE INC. $148.23 04/23/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202478602
Principal investigator 1 ABBVIE INC. $10.99 04/23/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202478611
Principal investigator 1 ABBVIE INC. $32.97 04/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202475767
Principal investigator 1 ABBVIE INC. $3,575.63 04/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202475795
Principal investigator 1 ABBVIE INC. $4,253.75 04/03/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202471341
Principal investigator 1 ABBVIE INC. $2,278.75 03/06/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202456858
Principal investigator 1 ABBVIE INC. $49.16 02/13/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202451520
Principal investigator 1 ABBVIE INC. $2,151.25 02/12/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202450754
Principal investigator 1 ABBVIE INC. $2,151.25 02/12/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202450758
Principal investigator 1 ABBVIE INC. $2,151.25 02/12/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202450762
Principal investigator 1 ABBVIE INC. $2,316.88 02/12/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202450768
Principal investigator 1 ABBVIE INC. $2,844.38 02/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202450396
Principal investigator 1 ABBVIE INC. $3,008.13 02/06/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202448078
Principal investigator 1 ABBVIE INC. $2,406.88 02/06/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202448729
Principal investigator 1 ABBVIE INC. $2,243.13 02/06/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202449397
Principal investigator 1 ABBVIE INC. $1,055.00 02/05/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202445766
Principal investigator 1 ABBVIE INC. $32.72 02/04/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202443752
Principal investigator 1 ABBVIE INC. $315.00 02/04/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202443857
Principal investigator 1 ABBVIE INC. $9.95 01/16/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202439553
Principal investigator 1 ABBVIE INC. $297.50 01/10/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202437941
Principal investigator 1 ABBVIE INC. $21.98 01/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202437797
Principal investigator 1 ABBVIE INC. $42.18 01/09/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202437801
Principal investigator 1 ABBVIE INC. $2,075.00 01/02/2025 Non-covered Recipient Entity
ACCESS CLINICAL TRIALS INC
M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 1202435974